Cargando…

Caution When Comparing the Impact of Corticosteroids in COVID-19

Detalles Bibliográficos
Autores principales:	Confalonieri, Marco, Salton, Francesco, Confalonieri, Paola, Rochwerg, Bram, Meduri, G. Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339403/ https://www.ncbi.nlm.nih.gov/pubmed/34366052 http://dx.doi.org/10.1016/j.chest.2021.04.026

Ejemplares similares

Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19
por: Salton, Francesco, et al.
Publicado: (2023)

Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?
por: Confalonieri, Marco, et al.
Publicado: (2022)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
por: Villar, Jesús, et al.
Publicado: (2020)

Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection
por: Confalonieri, Marco, et al.
Publicado: (2010)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
por: Salton, Francesco, et al.
Publicado: (2023)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
por: Meduri, G. Umberto, et al.
Publicado: (2021)

Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
por: Salton, Francesco, et al.
Publicado: (2020)

Airways to heaven: Caution needed when exercising during COVID-19
por: Della Guardia, Lucio, et al.
Publicado: (2021)

Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2020)

Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
por: Salton, Francesco, et al.
Publicado: (2023)

Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support
por: Torregiani, Chiara, et al.
Publicado: (2022)

Caution advised when considering “Exceptional” extended or single dose COVID-19 vaccination strategies
por: Hamidian Jahromi, Alireza, et al.
Publicado: (2021)

Caution is needed when assessing results of home birth
por: Verd, Sergio, et al.
Publicado: (2019)

Acute respiratory distress syndrome
por: Confalonieri, Marco, et al.
Publicado: (2017)

Limited role for bronchoalveolar lavage to exclude COVID-19 after negative upper respiratory tract swabs: a multicentre study
por: Geri, Pietro, et al.
Publicado: (2020)

Host-Based Treatments for Severe COVID-19
por: Mondini, Lucrezia, et al.
Publicado: (2023)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy
por: Mondini, Lucrezia, et al.
Publicado: (2023)

Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
por: Pelosi, Paolo, et al.
Publicado: (2022)

Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings
por: Salton, Francesco, et al.
Publicado: (2022)

Caution is needed when assessing results of home birth–Authors’ reply
por: Hutton, Eileen K, et al.
Publicado: (2019)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

WHO COVID-19 therapeutic guidelines
por: Rochwerg, Bram, et al.
Publicado: (2021)

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
por: Confalonieri, Paola, et al.
Publicado: (2022)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Video laryngoscopy in COVID-19 patients: a word of caution
por: Singh, Neha, et al.
Publicado: (2020)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?
por: Ruaro, Barbara, et al.
Publicado: (2021)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases?
por: Ruaro, Barbara, et al.
Publicado: (2020)

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung
por: Ruaro, Barbara, et al.
Publicado: (2021)

First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
por: Mastroianni, Fiore
Publicado: (2020)

Monkeypox virus under COVID-19: Caution for sexual transmission – Correspondence
por: Zhu, Fengya, et al.
Publicado: (2022)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_spntu62er095uufctiska2ikmd